NAD(P)H: Quinone oxidoreductase 1 (NQ01) C609T polymorphism and the risk of eight cancers for Japanese

International Journal of Clinical Oncology

Volumn 7, Issue 2, 2002, Pages 103-108

  Hamajima, N ^a   Matsuo, K ^a   Iwata, H ^a   Shinoda, M ^a   Yamamura, Y ^a   Kato, T ^a   Hatooka, S ^a   Mitsudomi, T ^a   Suyama, M ^a   Kagami, Y ^a   Ogura, M ^a   Ando, M ^a   Sugimura, Y ^b   Tajima, K ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Esophageal cancer; Lung cancer; NQO1 polymorphism; PCR CTPP; Smoking

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (QUINONE); DNA; PRIMER DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER; CANCER RISK; CASE CONTROL STUDY; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ESOPHAGUS CANCER; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; STOMACH CANCER; ADENOCARCINOMA; ADOLESCENT; AGE; ALLELE; CHEMISTRY; COLORECTAL TUMOR; COMPARATIVE STUDY; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; RISK; RISK FACTOR; SEX DIFFERENCE; SMOKING;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 0036001442     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101470200013     Document Type: Article

References (30)

1. Molecular epidemiology of human cancer: Contribution of mutation spectra studies of tumor suppressor genes
2. Single nucleotide polymorphisms and the future of genetic epidemiology
3. Polymorphisms and colorectal tumor risk
4. A systematic review of genetic polymorphisms and breast cancer risk
5. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers
6. NAD(P)H: Quinone oxidoreductase 1 (NQO1): Chemoprotection, bioactivation, gene regulation and genetic polymorphisms
7. Low NAD(P)H: Quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults
8. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia
9. Prevalence of the inactivating 609C→T polymorphism in the NAD(P)H: Quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia
10. Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking
11. NAD(P)H: Quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumor
12. Increased frequency of a null-allele for NAD(P)H: Quinone oxidoreductase in patients with urological malignancies
13. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: Quinone oxidoreductase polymorphism
14. Association of the NAD(P)H:quinone oxidoreductase 609 C > T polymorphism with a decreased lung cancer risk
15. The NAD(P)H: Quinone oxidoreductase polymorphism and lung cancer in Taiwan
16. The NAD(P)H: Quinone oxidoreductase 1 gene polymorphism and lung cancer: Differential susceptibility based on smoking behavior
17. Genetic polymorphisms of NAD(P)H:quinone oxidoreductase. CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China
18. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: A study of polymorphic human xenobiotic-metabolizing enzymes
19. Cytosolic activation of aromatic and heterocyclin amines. Inhibition by dicoumarol and enhancement in viral hepatitis B
20. Catalytic properties of NAD(P)H: Quinone acceptor oxidoreductase: Study involving mouse, human, and mouse-rat chimeric enzymes
21. Genotypephenotype relationships in studies of a polymorphism in NAD(P)H: Quinone exidoreductase 1
22. Gene-environment interaction and polymorphism studies for cancer risks in Hospital-based Epidemiologic Research Program at Aichi Cancer Center II(HERPACC-II)
23. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection
24. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping
25. NAD(P)H: Quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis
26. NAD(P)H: Quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin
27. Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H: Quinone oxidoreductase 1 gene
28. Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes
29. Adjustment of prognostic effects in prevalent case-control studies on genotype